Synageva Prices 2.15M Share Public Offering at $47.53/Share

Synageva BioPharma GEVA today announced the pricing of its previously announced underwritten public offering of common stock consisting of 2,150,000 shares at $47.53 per share. In connection with this offering, Synageva granted to the underwriters a 30-day option to purchase 322,500 additional shares of common stock. Morgan Stanley and J.P. Morgan are acting as joint book-running managers in the offering, and Cowen and Company, Canaccord Genuity Inc., and Leerink Swann LLC are acting as co-managers in the offering. The securities described above are being offered by Synageva pursuant to a Form S-3 shelf registration See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsGuidanceManagement
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!